Biocept Expands Non-Small Cell Lung Cancer Diagnostic Capabilities To Address EGFR Mutations
Lung Cancer, News
Biocept, Inc., a molecular oncology diagnostics company dedicated to biomarker analysis of circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) has recently announced the launch of the company’s EGFR ... Read more